Quality of Life in Understanding Disease
Bruce Crawford, MA, MPH
Director, Patient Reported Outcomes and Regulatory Consulting
Operations Director, USA
Mapi Values
19 October 2005
Quality of life assessment has been gaining importance to understand the full impact of disease on the patient. Increasingly, quality of life assessments have been implemented in clinical trials and epidemiologic studies outside of the development language. It is important to understand cultural and linguistic differences and how they are captured in quality of life assessment. This lecture provided a background on quality of life assessment, development, and translation issues.
Mr. Crawford has kindly given permission to put the handout of his talk on the MITA website (in PDF format, requires Adobe Reader).
